期刊文献+

HPLC法测定富马酸沃诺拉赞原料药中吡啶-3-磺酸的含量 被引量:2

Determination of Pyridine-3-sulfonic in Vonoprazan Fumarate by HPLC
原文传递
导出
摘要 目的建立测定富马酸沃诺拉赞原料药中吡啶-3-磺酸的高效液相色谱(HPLC)法。方法色谱柱为Inertsil ODS-3 C18柱(4.6 mm×150 mm,5μm),以0.025 mol·L-1磷酸钠溶液(用磷酸调节p H值至6.8)-乙腈(98∶2,V/V)为流动相A,乙腈为流动相B,进行线性梯度洗脱,检测波长为210 nm,柱温为25℃,流速1.0 m L·min^(-1),进样量20μL。结果在选定的色谱条件下,吡啶-3-磺酸与相邻色谱峰分离良好,在0.197 4~1.974 3μg·mL^(-1)浓度范围内与峰面积呈良好的线性关系,线性方程为Y=41 638X+1 137.5,相关系数r=0.999 8;平均回收率为103.6%,RSD%为1.34%(n=12); 6批样品中吡啶-3-磺酸的含量分别为0.001 8%、0.001 7%、0.001 5%、0.001%、0.004%及0.004%。结论本方法精密度良好,灵敏度高,准确度好,适用于富马酸沃诺拉赞原料药中吡啶-3-磺酸的检测。 OBJECTIVE To establish an HPLC method for the determination of pyridine-3-sulfonic acid in vonoprazan fumarate.METHODS Inertsil ODS-3 C18( 4.6 mm×150 mm,5 μm) column was used,0.025 mol·L-1 sodium phosphate solution( pH adjusted to 6.8 with phosphori acid)-acetonitrile( 98 ∶2,V/V) as mobile phase A,acetonitrile as mobile phase B,using linear gradient elution.The detection wavelength was 210 nm,column temperature was 25 ℃,flow rate was 1.0 m L·min-1 and the sample volume was 20 μL.RESULTS Under the selected chromatographic conditions,pyridine-3-sulfonic acid was separated from adjacent chromatographic peaks,the concentration in the range of 0.197 4-1.974 3 μg·mL-1 had good linear relationship with the peak area,the linear equation was Y = 41 638 X+1 137.5,the correlation coefficient was r = 0.999 8. The average recovery rate was 103.6% and RSD% was 1.34%( n= 12).The content of pyridine-3-sulfonic acid in 6 batches of samples were 0.001 8%,0.001 7%,0.001 5%,0.001%,0.004% and0.004% respectively. CONCLUSION The method has been verified by methodology,and the method has good precision,high sensitivity and good accuracy. It is suitable for the detection of pyridine-3-sulfonic acid in the vonoprazan fumarate.
作者 乐志艳 肖敏 方潇颖 LE Zhiyan;XIAO Min;FANG Xiaoying(Institute for Food and Drug Control of Jiangxi,Fuzhou,Jiangxi 344000,China;Jiangxi University of Traditional Chinese Medicine,Nanchang,Jiangxi 330004,China)
出处 《今日药学》 CAS 2019年第1期809-812,共4页 Pharmacy Today
关键词 吡啶-3-磺酸 富马酸沃诺拉赞 有关物质 方法学验证 高效液相色谱法 pyridine-3-sulfonic vonoprazan fumarate related substances methodological validation HPLC
  • 相关文献

参考文献4

二级参考文献27

  • 1刘丽芳.药品标准中HPLC法色谱条件的优化与系统适用性试验的重要性[J].中国药品标准,2005,6(1):3-6. 被引量:6
  • 2国家食品药品监督管理局.化学药物杂质研究的技术指导原则[EB/OL].2005.http://www.sda.gov.cn/gsz05106/03.pdf.
  • 3ICH Q3A (R2). Impurities in New Drug Substances (Revised Guideline) [EB/OL]. http://www.ich.org/LOB/media/ MEDIA422.pdf.
  • 4ICH Q3B (R2). Impurities in New Drug Products (Revised Guideline) [EB/OL]. http://www.ich.org/LOB/media/ MEDIA421 .pdf.
  • 5FDA. ANDAs: Impurities in Drug Products [EB/OL]. http:// www.fda.gov/downloads/Drugs/GuidanceComplianceRegula torylnformation/Guidances/ucm072861 .pdf.
  • 6FDA. ANDAs: Impurities in Drug Substances [EB/OL]. http://www, fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM 172002.pdf.
  • 7Hugh JC, Kenneth JN. Sample selection for analytical method development. Handbook of Isolation and Characterization of Impurities in Pharmaceuticals. Separation Science and Technology Series [M]. Vol 5, Sandiego CA USA: Academic Press, 2003: 145-164.
  • 8Bari SB, Kadam BR, Jaiswal YS, et al. Impurity profile: Significance in active pharmaceutical ingredient EJ]. Eurasian JAnal Chem, 2007, 2 (1) : 32-53.
  • 9Hewitt EF, Lukulay P, Galushko S. Implementation of a rapid and automated high performance liquid chromatography method development strategy for pharmaceutical drug candidates[J]. J ChromatogrA, 2006, 1107: 79-87.
  • 10Xiao KP, Xiong Y, Liu FZ, et al. Efficient method development strategy for challenging separation of pharmaceutical molecules using advanced chromatographic technologies [J]. J ChromatogrA 2007, 1163: 145-156.

共引文献22

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部